About Baxter International (NYSE:BAX)
Baxter International Inc. provides a portfolio of healthcare products. The company operates through North and South America; Europe, Middle East and Africa; and Asia-Pacific segments. It offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; renal replacement therapies and other organ support therapies focused in the intensive care unit; sterile intravenous (IV) solutions, IV therapies, infusion pumps, administration sets, and drug reconstitution devices; and parenteral nutrition therapies. The company also provides biological products and medical devices, and surgical hemostat and sealant products used in surgical procedures for hemostasis, tissue sealing, and adhesion prevention; premixed and oncology drug platforms, inhaled anesthesia and critical care products, and pharmacy compounding services; and generic injectable pharmaceuticals. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and by patients at home under physician supervision. The company sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was founded in 1931 and is headquartered in Deerfield, Illinois.
Industry, Sector and Symbol
Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
Trailing P/E Ratio29.97
Forward P/E Ratio25.71
Sales & Book Value
Annual Sales$10.56 billion
Price / Sales3.77
Cash Flow$3.8738 per share
Price / Cash19.18
Book Value$16.73 per share
Price / Book4.44
EPS (Most Recent Fiscal Year)$2.48
Net Income$717 million
Return on Equity15.70%
Return on Assets8.44%
Baxter International (NYSE:BAX) Frequently Asked Questions
What is Baxter International's stock symbol?
Baxter International trades on the New York Stock Exchange (NYSE) under the ticker symbol "BAX."
How often does Baxter International pay dividends? What is the dividend yield for Baxter International?
Baxter International announced a quarterly dividend on Tuesday, May 8th. Investors of record on Friday, June 1st will be given a dividend of $0.19 per share on Monday, July 2nd. This represents a $0.76 dividend on an annualized basis and a dividend yield of 1.02%. The ex-dividend date is Thursday, May 31st. This is an increase from Baxter International's previous quarterly dividend of $0.16. View Baxter International's Dividend History.
How will Baxter International's stock buyback program work?
Baxter International announced that its board has initiated a stock buyback program on Wednesday, February 21st 2018, which permits the company to buyback $1,500,000,000.00 in shares, according to EventVestor. This buyback authorization permits the company to buy shares of its stock through open market purchases. Shares buyback programs are often an indication that the company's management believes its shares are undervalued.
How were Baxter International's earnings last quarter?
Baxter International Inc (NYSE:BAX) released its earnings results on Thursday, April, 26th. The medical instruments supplier reported $0.70 earnings per share for the quarter, topping analysts' consensus estimates of $0.62 by $0.08. The medical instruments supplier earned $2.68 billion during the quarter, compared to analysts' expectations of $2.62 billion. Baxter International had a return on equity of 15.70% and a net margin of 7.75%. Baxter International's revenue was up 8.2% compared to the same quarter last year. During the same period in the previous year, the company earned $0.58 earnings per share. View Baxter International's Earnings History.
When is Baxter International's next earnings date?
What guidance has Baxter International issued on next quarter's earnings?
Baxter International issued an update on its FY18 earnings guidance on Thursday, April, 26th. The company provided earnings per share (EPS) guidance of $2.85-2.93 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $2.78. The company issued revenue guidance of $11.3-11.4 billion, compared to the consensus revenue estimate of $11.25 billion.Baxter International also updated its Q2 guidance to $0.69-0.71 EPS.
What price target have analysts set for BAX?
16 analysts have issued 1-year price objectives for Baxter International's stock. Their forecasts range from $62.00 to $83.00. On average, they anticipate Baxter International's stock price to reach $72.7333 in the next year. View Analyst Ratings for Baxter International.
Who are some of Baxter International's key competitors?
Some companies that are related to Baxter International include 3M (MMM), Stryker (SYK), Becton Dickinson and (BDX), Boston Scientific (BSX), FRESENIUS SE &/S (FSNUY), ABIOMED (ABMD), ResMed (RMD), Teleflex (TFX), Dexcom (DXCM), ICU Medical (ICUI), Hill-Rom (HRC), Insulet (PODD), Globus Medical (GMED), Penumbra (PEN) and Haemonetics (HAE).
Who are Baxter International's key executives?
Baxter International's management team includes the folowing people:
- Mr. José E. Almeida, Chairman, Pres & CEO (Age 56)
- Mr. James K. Saccaro, Exec. VP & CFO (Age 45)
- Mr. Sean Martin, Sr. VP & Gen. Counsel (Age 55)
- Mr. Brik V. Eyre, Sr. VP & Pres of Americas (Age 54)
- Mr. Giuseppe Accogli, Sr. VP & Pres of Global Bus.es (Age 47)
Has Baxter International been receiving favorable news coverage?
News headlines about BAX stock have been trending positive this week, according to Accern Sentiment. The research firm identifies negative and positive media coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Baxter International earned a coverage optimism score of 0.34 on Accern's scale. They also gave news stories about the medical instruments supplier an impact score of 43.35 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the next several days.
Who are Baxter International's major shareholders?
Baxter International's stock is owned by a number of of institutional and retail investors. Top institutional investors include BlackRock Inc. (8.05%), Veritas Asset Management LLP (1.77%), Northern Trust Corp (1.65%), Wells Fargo & Company MN (1.07%), Old Mutual Global Investors UK Ltd. (0.65%) and Legal & General Group Plc (0.53%). Company insiders that own Baxter International stock include Albert P L Stroucken, Brik V Eyre, Carole J Shapazian, Giuseppe Accogli, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Third Point Llc and Thomas T Stallkamp. View Institutional Ownership Trends for Baxter International.
Which major investors are selling Baxter International stock?
BAX stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Prudential Financial Inc., American Century Companies Inc., Wells Fargo & Company MN, Aristotle Capital Management LLC, CI Global Investments Inc., Veritas Asset Management LLP and Northern Trust Corp. Company insiders that have sold Baxter International company stock in the last year include Brik V Eyre, Carole J Shapazian, Giuseppe Accogli, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Third Point Llc and Thomas T Stallkamp. View Insider Buying and Selling for Baxter International.
Which major investors are buying Baxter International stock?
BAX stock was bought by a variety of institutional investors in the last quarter, including PNC Financial Services Group Inc., Point72 Asset Management L.P., The Manufacturers Life Insurance Company, Natixis, Old Mutual Global Investors UK Ltd., BNP Paribas Arbitrage SA, Mackay Shields LLC and Eaton Vance Management. View Insider Buying and Selling for Baxter International.
How do I buy shares of Baxter International?
Shares of BAX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Baxter International's stock price today?
One share of BAX stock can currently be purchased for approximately $74.30.
How big of a company is Baxter International?
Baxter International has a market capitalization of $40.28 billion and generates $10.56 billion in revenue each year. The medical instruments supplier earns $717 million in net income (profit) each year or $2.48 on an earnings per share basis. Baxter International employs 47,000 workers across the globe.
How can I contact Baxter International?
Baxter International's mailing address is One Baxter Parkway, DEERFIELD IL, 60015. The medical instruments supplier can be reached via phone at 224-948-2000 or via email at [email protected]
MarketBeat Community Rating for Baxter International (BAX)MarketBeat's community ratings are surveys of what our community members think about Baxter International and other stocks. Vote "Outperform" if you believe BAX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BAX will underperform the S&P 500 over the long term. You may vote once every thirty days.